These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22339194)

  • 1. Susceptibility of Gram-negative bacteria to isepamicin: a systematic review.
    Falagas ME; Karageorgopoulos DE; Georgantzi GG; Sun C; Wang R; Rafailidis PI
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):207-18. PubMed ID: 22339194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of isepamicin and other antibiotics against gram-negative bacilli from intensive care units (ICU) in Belgium.
    Belgian Isepamicin Multicenter Study Group
    Acta Clin Belg; 2001; 56(5):307-15. PubMed ID: 11774843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the efficacy of isepamicin in the adult core clinical trial programme.
    Carbon C
    J Chemother; 1995 Jun; 7 Suppl 2():79-85. PubMed ID: 8622115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance.
    Samonis G; Maraki S; Vouloumanou EK; Georgantzi GG; Kofteridis DP; Falagas ME
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3191-8. PubMed ID: 22752194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of isepamicin in vitro efficiency in Gram negative bacteria efficacy of isepamicin.
    Yeliz TC; Ali HB; Sarah AF; Sreylis N; Kubra HU; Asuman B
    Indian J Med Microbiol; 2021 Jan; 39(1):59-62. PubMed ID: 33610258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
    Rodriguez-Noriega E; Esparza-Ahumada S; Morfin-Otero R
    J Chemother; 1995 Jun; 7 Suppl 2():155-60. PubMed ID: 8622105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Herbrecht R; Blaise D; Espinouse D; Leblond V; Sadoun A; Sauvage C; Cordonnier C; Minozzi C
    J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
    Beaucaire G
    J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily isepamicin treatment in complicated urinary tract infections.
    Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
    J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
    Tripodi MF; Andreana A; Sarnataro G; Ragone E; Adinolfi LE; Utili R
    Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):73-5. PubMed ID: 11245333
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
    Viganò A; Principi N
    J Chemother; 1995 Jun; 7 Suppl 2():95-101. PubMed ID: 8622117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
    Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
    J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of nosocomial isolates against a new aminoglycoside isepamicin.
    Kapil A; Bali R; Das BK
    Indian J Med Res; 2001 Feb; 113():60-2. PubMed ID: 21910285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside resistance. Enzymatic mechanisms in clinical bacterial strains in Slovakia during the last decade.
    Kallová J; Kettner M; Macicková T; Milosovic P; Langsádl L
    FEMS Immunol Med Microbiol; 1997 Sep; 19(1):89-94. PubMed ID: 9322073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isepamicin versus amikacin for the treatment of acute pyelonephritis in children.
    Kafetzis DA; Maltezou HC; Mavrikou M; Siafas C; Paraskakis I; Delis D; Bartsokas C
    Int J Antimicrob Agents; 2000 Feb; 14(1):51-5. PubMed ID: 10717501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of resistance to dactimicin and isepamicin in clinical strains of gram-negative rods isolated in Czechoslovakia].
    Kettner M; Miller GH; Inouye S
    Bratisl Lek Listy; 1992 Mar; 93(3):131-5. PubMed ID: 1525686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity.
    Jones RN
    J Chemother; 1995 Jun; 7 Suppl 2():7-16. PubMed ID: 8622113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.